News
We provide the latest news from the world of economics and finance
(RTTNews) - GE HealthCare (GEHC) on Monday said its next-generation diagnostic viewer, View, part of the Genesis Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration.
The company said View is a cloud-native, zero-footprint diagnostic imaging viewer designed to streamline radiology workflows and provide radiologists with secure access to diagnostic images from virtually anywhere.
Studies cited by the company show radiologists can spend up to 44% of their time on non-interpretive tasks, such as navigating complex software interfaces or waiting for images to load, which can affect productivity and turnaround times.
GE HealthCare said the new viewer aims to reduce these inefficiencies by providing a unified workspace that enables faster collaboration and more efficient image review across care teams.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2026 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
E-mail: 24_support@j2t.com
